Shingrix® Shingles Vaccine Indicated for People 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

Features

• SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
• SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
• SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
• A single dose after reconstitution is 0.5 mL
• Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
• 1 Dose

More Information

• SDS